Celebrating Peptide Innovation — Shaping Tomorrow’s Therapies
PepTIDx 2026 gathers leading innovators in peptide science
—from world‑class academic researchers to senior biotech and pharma decision‑makers
—for two days of focused, high‑level exchange on the therapeutic breakthroughs redefining metabolic health and next‑generation peptide modalities.
Sponsored by PolyPeptide Group and chaired by Bernard Thorens, this forum provides rare access to the ideas, technologies, and scientific perspectives driving the field forward.
Speakers
Chairman & Moderator
Bernard Thorens, Professor emeritus of the University of Lausanne
Speakers
Lotte Bjerre Knudsen
Chief Scientific Advisor for the SCO of Novo Nordisk
Katharina Timper
Professor of Clinical Nutritional Medicine,
Univ.-Prof. Dr. med., TUM (Technical University of Munich),
Helmholtz Munich and Else Kröner Fresenius Center for Clinical Nutritional Medicine
Cristina M Rondinone
CEO and founder Pep2Tango Therapeutics
Robert Augustin
Business Development and Licensing,
Boehringer Ingelheim
Patrick Couvreur
Emeritus Professor at Paris-Saclay University
Bradley L. Pentelute
Professor of Chemistry at MIT
Jason Chin
Founding Director of the Generative Biology Institute (GBI).
Bruno Correia
Associate Professor, Laboratory of Protein Design & Immunoengineering, EPFL
(École Polytechnique Fédérale de Lausanne)
Andrew Rutter
Consultant Rutterdesign
Round-tables
Day 1
Metabolic space
What’s next ?
Dive into the evolving peptide landscape with insights from global leaders shaping next-generation therapeutics.
Topics include GLP-1 innovations, the clinician’s view on metabolic diseases.
Afternoon sessions explore emerging peptide classes, manufacturing trends, and the expanding metabolic space.
Day 2
The promises
of peptide science for medicine
Day two focuses on the technologies
advancing peptide discovery and production.
Experts in peptide discovery using AI and novel technologies, in chemical and biological peptide synthesis, flow chemistry and peptide formulation,will share strategies driving efficiency and scalability
Discussions will explore how these disciplines converge to shape the future of peptide development.
Program
7th September 2026
8:45
Welcoming
Bernard Thorens
& PolyPeptide Group
9:00
GLP-1: the medicines, the biology,
and the learnings
Lotte Bjerre Knudsen,
Chief Scientific Advisor for the SCO of Novo Nordisk
9:45
GLP-1 Analogues and their impact on patients – the doctor’s perspective
Katharina Timper,
Professor of Clinical Nutritional Medicine,
Univ.-Prof. Dr. med., TUM (Technical University of Munich),
Helmholtz Munich and Else Kröner Fresenius Center for Clinical Nutritional Medicine
10:30
Break
11:00
Discovery of novel unimolecular tetra-agonist peptides for the treatment of obesity and related disorders
Cristina M Rondinone,
CEO and founder Pep2Tango Therapeutics
11:45
From GLP-1 to Nutrient-Stimulated Polyagonists: from T2D to Obesity to Cardiorenalmetabolism and Beyond
Robert Augustin,
Business Development and Licensing,
Boehringer Ingelheim
12:30
Lunch
14:00
Nano- and microtechnologies for the oral delivery of peptides
Patrick Couvreur,
Emeritus Professor at Paris-Saclay University
14:45 – 15:45
Round Table
Bernard Thorens
Metabolic space
What’s next ?
18:00
Cocktail hour
19:00
Dinner
21:00
Gala
8th September 2026
8:00
The Infinite Loop: ML for Discovery, Delivery, and Rapid Manufacturing of Potential Medicines
Bradley L. Pentelute,
Professor of Chemistry at MIT
8:45
Reprograming the genetic code to unlock the potential of recombinant strategy for peptide manufacturing
Jason Chin,
Founding Director of the Generative Biology Institute (GBI)
9:30
Break
10:00
Advances in AI Enabled Peptide Design: Structural Trends and the Expanding Role of AlphaFold
Bruno Correia,
Associate Professor, Laboratory of Protein Design & Immunoengineering, EPFL
10:45
Diseconomies of Scale; how Automation, Process Intensification and Politics are changing Manufacture of Complex Molecules
Andrew Rutter,
Consultant Rutterdesign
11:30
Round Table
Bernard Thorens
The promises of peptide science for medicine
12:30
Lunch
13:30 – 14:00
Closure
Gala Evening at Six Senses Crans-Montana
The PepTIDx Gala brings together the full forum community for an elegant evening celebrating the scientific progress and collaborative spirit that define this gathering.
Set against an inspiring alpine backdrop, guests will enjoy a curated dinner featuring regional cuisine and wines, in an atmosphere that reflects both the rigor and the warmth of this community.
A scientific poster showcase will spotlight emerging discoveries, technologies, and collaborations from selected participants covering next generation peptide therapeutics and the innovations shaping the field. Informal by design, the showcase creates space for the kind of candid, peer to peer exchange that complements the structured program — a rare opportunity to explore new ideas and recognize groundbreaking contributions from both academia and industry.
The Gala is not a departure from the forum’s purpose. It is a continuation of it — bridging science, innovation, and impact in a setting worthy of the work being celebrated.